Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses (Proceeding of the National Academy of Siences of the United States of America (308) 105, (10495-10500) DOI: 10.1073/pnas.0802423105);Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 30, 2008, Pages 10495-10500

  Hashiguchi, Masaaki ^a   Kobori, Hiroko ^a   Ritprajak, Patcharee ^a   Kamimura, Yosuke ^a   Kozono, Haruo ^b   Azuma, Miyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Allergy; CD8; Contact hypersensitivity; Cosignal; T cell activation

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B7 H3; MONOCLONAL ANTIBODY TLT 2; PROTEIN B7 H3; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS LIKE TRANSCRIPT 2;

ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

MURINAE;

EID: 48749093493     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0807700105     Document Type: Erratum

References (36)

1. Carreno BM, Collins M (2002) The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 20:29-53.
2. Chen L (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4:336-347.
3. Greenwald RJ, Freeman GJ, Sharpe AH (2005) The B7 family revisited. Annu Rev Immunol 23:515-548.
4. Chapoval AI, et al. (2001) B7-H3: A costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol 2:269-274.
5. Ferlazzo G, et al. (2002) T lymphocytes express B7 family molecules following interaction with dendritic cells and acquire bystander costimulatory properties. Eur J Immunol 32:3092-3101.
6. Suh WK, et al. (2003) The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 4:899-906.
7. Prasad DV, et al. (2004) Murine B7-H3 is a negative regulator of T cells. J Immunol 173:2500-2506.
8. Wu CP, et al. (2006) Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 12:457-459.
9. Sun Y, et al. (2006) B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 53:143-151.
10. Zhou YH, et al. (2007) 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells. Tissue Antigens 70:96-104.
11. Roth TJ, et al. (2007) B7-H3 ligand expression by prostate cancer: A novel marker of prognosis and potential target for therapy. Cancer Res 67:7893-7900.
12. Zang X, et al. (2007) B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci USA 104:19458-19463.
13. Saatian B, et al. (2004) Expression of genes for B7-H3 and other T cell ligands by nasal epithelial cells during differentiation and activation. Am J Physiol Lung Cell Mol Physiol 287:L217-L225.
14. Kim J, et al. (2005) Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells. Am J Respir Cell Mol Biol 33:280-289.
15. Stanciu LA, et al. (2006) Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis 193:404-412.
16. Suh WK, et al. (2004) The immune regulatory protein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci USA 101:12969-12973.
17. Sun X, et al. (2003) Mouse B7-H3 induces antitumor immunity. Gene Ther 10:1728-1734.
18. + cytolytic T cells. J Immunol 173:5445-5450.
19. Lupu CM, et al. (2006) An orthotopic colon cancer model for studying the B7-H3 antitumor effect in vivo. J Gastrointest Surg 10:635-645.
20. Ma L, et al. (2007) Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy. J Hepatol 46:98-106.
21. Wang L, et al. (2005) B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol 35:428-438.
22. Ling V, et al. (2003) Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: Divergent history of functional redundancy and exon loss. Genomics 82:365-377.
23. Fukushima A, et al. 2007 B7-H3 regulates the development of experimental allergic conjunctivitis in mice. Immunol Lett 113:52-57.
24. + regulatory T cells: Role of B7-H3 expression and antigen presentation. Eur J Immunol 37:2117-2126.
25. Sun M, et al. (2002) Characterization of mouse and human B7-H3 genes. J Immunol 168:6294-6297.
26. Youngnak P, et al. (2003) Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 307:672-677.
27. King RG, Herrin BR, Justement LB (2006) Trem-like transcript 2 is expressed on cells of the myeloid/granuloid and B lymphoid lineage and is up-regulated in response to inflammation. J Immunol 176:6012-6021.
28. Sedy JR, et al. (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6:90-98.
29. Allcock RJ, et al. (2003) The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. Eur J Immunol 33:567-577.
30. Colonna M (2003) TREMs in the immune system and beyond. Nat Rev Immunol 3:445-453.
31. Klesney-Tait J, Turnbull IR, Colonna M (2006) The TREM receptor family and signal integration. Nat Immunol 7:1266-1273.
32. Hogquist KA, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76:17-27.
33. + T cells. J Immunol 172:7306-7314.
34. Oikawa T, et al. (2006) Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J Immunol 177:4281-4287.
35. Nuriya S, Yagita H, Okumura K, Azuma M (1996) The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int Immunol 8:917-926.
36. Tsushima F, et al. (2003) Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol 33:2773-2782.